Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Mol Cancer Ther. 2013 Oct 15;12(12):10.1158/1535-7163.MCT-13-0547. doi: 10.1158/1535-7163.MCT-13-0547

Figure 2. EVRi abrogates oncogenic growth factor signaling.

Figure 2

Phosphoproteomic RTK antibody arrays were performed on xenografts harvested at the end of study. (A) Heatmap depicting sample-to-sample correlation by unsupervised hierarchical clustering of Pearson coefficient values. (B) HER (EGFR, ErbB2, ErbB3, ErbB4) and VEGF (VEGFR1, VEGFR2, VEGFR3) receptor phosphorylation. *p<0.05, **p<0.01, ***p<0.001.